GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shandong Bailong Chuangyuan Bio-Tech Co Ltd (SHSE:605016) » Definitions » Change In Receivables

Shandong Bailong Chuangyuan Bio-Tech Co (SHSE:605016) Change In Receivables : ¥0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shandong Bailong Chuangyuan Bio-Tech Co Change In Receivables?

Shandong Bailong Chuangyuan Bio-Tech Co's change in receivables for the quarter that ended in Sep. 2024 was ¥0 Mil. It means Shandong Bailong Chuangyuan Bio-Tech Co's Accounts Receivable stayed the same from Jun. 2024 to Sep. 2024 .

Shandong Bailong Chuangyuan Bio-Tech Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-61 Mil. It means Shandong Bailong Chuangyuan Bio-Tech Co's Accounts Receivable increased by ¥61 Mil from Dec. 2022 to Dec. 2023 .

Shandong Bailong Chuangyuan Bio-Tech Co's Accounts Receivable for the quarter that ended in Sep. 2024 was ¥257 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shandong Bailong Chuangyuan Bio-Tech Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 81.23.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shandong Bailong Chuangyuan Bio-Tech Co's liquidation value for the three months ended in Sep. 2024 was ¥374 Mil.


Shandong Bailong Chuangyuan Bio-Tech Co Change In Receivables Historical Data

The historical data trend for Shandong Bailong Chuangyuan Bio-Tech Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Bailong Chuangyuan Bio-Tech Co Change In Receivables Chart

Shandong Bailong Chuangyuan Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial -43.65 -24.46 -16.93 -11.55 -60.72

Shandong Bailong Chuangyuan Bio-Tech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shandong Bailong Chuangyuan Bio-Tech Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Bailong Chuangyuan Bio-Tech Co  (SHSE:605016) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shandong Bailong Chuangyuan Bio-Tech Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=257.285/289.039*91
=81.23

2. In Ben Graham's calculation of liquidation value, Shandong Bailong Chuangyuan Bio-Tech Co's accounts receivable are only considered to be worth 75% of book value:

Shandong Bailong Chuangyuan Bio-Tech Co's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=408.658-306.302+0.75 * 257.285+0.5 * 158.235
=374

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Bailong Chuangyuan Bio-Tech Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shandong Bailong Chuangyuan Bio-Tech Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Bailong Chuangyuan Bio-Tech Co Business Description

Traded in Other Exchanges
N/A
Address
Dexin Street, National High-tech Industrial Development Zone, Yucheng, Shandong Province, Dezhou, CHN, 251200
Shandong Bailong Chuangyuan Bio-Tech Co Ltd is engaged in the research and development, production and sales of prebiotic series products, dietary fiber series products, other starch sugar (alcohol) series products and healthy sweetener products.
Executives
Zhao De Xuan senior management
Dou Bao De Director
An Lian Lian Director
Zhang An Guo Director

Shandong Bailong Chuangyuan Bio-Tech Co Headlines

No Headlines